Published in Arch Ophthalmol on January 01, 2012
The Early Treatment for Retinopathy of Prematurity Study (ETROP) | NCT00027222
Length of day during early gestation as a predictor of risk for severe retinopathy of prematurity. Ophthalmology (2013) 0.79
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial. Pediatr Res (2016) 0.75
A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology (2003) 4.88
A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology (2004) 3.48
Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol (2005) 3.42
Imaging the infant retina with a hand-held spectral-domain optical coherence tomography device. Am J Ophthalmol (2008) 3.17
15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol (2005) 3.13
Dynamics of human foveal development after premature birth. Ophthalmology (2011) 3.11
Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging. Ophthalmology (2009) 2.99
Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology (2006) 2.89
The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics (2005) 2.65
Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol (2003) 2.37
Refractive surgery in children: treatment options, outcomes, and controversies. Am J Ophthalmol (2009) 2.31
Retracted A BLOC-1 mutation screen reveals that PLDN is mutated in Hermansky-Pudlak Syndrome type 9. Am J Hum Genet (2011) 2.25
Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol (2002) 2.13
Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children. Invest Ophthalmol Vis Sci (2010) 2.11
Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration. J Neuroophthalmol (2009) 2.10
Treatment of symptomatic convergence insufficiency with a home-based computer orthoptic exercise program. J AAPOS (2011) 2.04
Multicenter trial of early treatment for retinopathy of prematurity: study design. Control Clin Trials (2004) 1.94
Retinopathy of prematurity in infants with birth weight>or=1250 grams-incidence, severity, and screening guideline cost-analysis. J AAPOS (2006) 1.86
Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology (2007) 1.73
Neonatologists' practices and experiences in arranging retinopathy of prematurity screening services. Pediatrics (2007) 1.68
Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol (2010) 1.64
Systematic review of digital imaging screening strategies for retinopathy of prematurity. Pediatrics (2008) 1.64
Choroid development and feasibility of choroidal imaging in the preterm and term infants utilizing SD-OCT. Invest Ophthalmol Vis Sci (2013) 1.64
Arrested development: high-resolution imaging of foveal morphology in albinism. Vision Res (2010) 1.62
Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age. J AAPOS (2008) 1.55
Strabismus and amblyopia in bilateral Peters anomaly. J AAPOS (2006) 1.54
Hermansky-Pudlak syndrome (HPS5) in a nonagenarian. J AAPOS (2013) 1.52
Retinopathy of prematurity care: patterns of care and workforce analysis. J AAPOS (2008) 1.48
The prevalence of attention-deficit/hyperactivity disorder among persons with albinism. J Child Neurol (2007) 1.47
Treatment options for symptomatic convergence insufficiency. Arch Ophthalmol (2008) 1.46
Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity. Arch Ophthalmol (2012) 1.43
The unique association of iris heterochromia with Hermansky-Pudlak syndrome. J AAPOS (2013) 1.39
Effect of decreasing target oxygen saturation on retinopathy of prematurity. J AAPOS (2010) 1.38
Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age. J AAPOS (2008) 1.36
Axenfeld-Rieger syndrome: new perspectives. Br J Ophthalmol (2011) 1.35
Visual acuity through Bangerter filters in nonamblyopic eyes. J AAPOS (2011) 1.34
Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA. J Inherit Metab Dis (2012) 1.32
Macular features from spectral-domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. Retina (2011) 1.31
Standard image of plus disease in retinopathy of prematurity. Arch Ophthalmol (2006) 1.27
The natural history of glaucoma and ocular hypertension after pediatric cataract surgery. J AAPOS (2006) 1.27
Enhanced video indirect ophthalmoscopy (VIO) via robust mosaicing. Biomed Opt Express (2011) 1.24
Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age. Ophthalmology (2008) 1.22
Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age. J AAPOS (2013) 1.21
Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity. Ophthalmology (2005) 1.21
Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. Hum Genet (2003) 1.19
Spectrum of foveal development in albinism detected with optical coherence tomography. J AAPOS (2006) 1.18
Subfoveal fluid in healthy full-term newborns observed by handheld spectral-domain optical coherence tomography. Am J Ophthalmol (2011) 1.18
Functional visual loss in adults and children patient characteristics, management, and outcomes. Ophthalmology (2005) 1.17
Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity Study (ETROP). Arch Ophthalmol (2006) 1.14
Central corneal thickness: congenital cataracts and aphakia. Am J Ophthalmol (2007) 1.11
Strabismus associated with thyroid eye disease. Curr Opin Ophthalmol (2007) 1.10
Clinical characteristics of children with severe visual impairment but favorable retinal structural outcomes from the Early Treatment for Retinopathy of Prematurity (ETROP) study. J AAPOS (2013) 1.10
Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol Vis (2006) 1.10
Astigmatism in the Early Treatment for Retinopathy Of Prematurity Study: findings to 3 years of age. Ophthalmology (2008) 1.09
Combining ROPtool measurements of vascular tortuosity and width to quantify plus disease in retinopathy of prematurity. J AAPOS (2011) 1.07
Exploratory Dijkstra forest based automatic vessel segmentation: applications in video indirect ophthalmoscopy (VIO). Biomed Opt Express (2012) 1.07
Optical treatment of strabismic and combined strabismic-anisometropic amblyopia. Ophthalmology (2011) 1.07
Computer-assisted measurement of retinal vascular width and tortuosity in retinopathy of prematurity. Arch Ophthalmol (2010) 1.05
Factors associated with horizontal reoperation in infantile esotropia. J AAPOS (2002) 1.05
Office probing for treatment of nasolacrimal duct obstruction in infants. J AAPOS (2014) 1.04
Computer-assisted assessment of plus disease in retinopathy of prematurity using video indirect ophthalmoscopy images. Retina (2008) 1.04
A randomized trial of increasing patching for amblyopia. Ophthalmology (2013) 1.03
Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets. AAPS PharmSciTech (2008) 1.00
Astigmatism progression in the early treatment for retinopathy of prematurity study to 6 years of age. Ophthalmology (2011) 0.99
Pseudotumor cerebri in idiopathic aplastic anemia. J AAPOS (2003) 0.98
Severe visual impairment in children with mild or moderate retinal residua following regressed threshold retinopathy of prematurity. J AAPOS (2007) 0.98
Plus disease. Surv Ophthalmol (2009) 0.97
Visual acuity at 10 years in Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) study eyes: effect of retinal residua of retinopathy of prematurity. Arch Ophthalmol (2006) 0.97
A strabismus susceptibility locus on chromosome 7p. Proc Natl Acad Sci U S A (2003) 0.97
Reading acuity in albinism: evaluation with MNREAD charts. J AAPOS (2011) 0.97
Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years. Arch Ophthalmol (2010) 0.95
MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2). Am J Hum Genet (2003) 0.95